Publisher
Heighten Science Publications Corporation
Reference20 articles.
1. 1. Huynh T, McGown I, Cowley D, Nyunt O, Leong GM, et al. The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21- hydroxylase deficiency. Clin Biochem Rev 2009; 30: 75-86. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19565027
2. 2. Khalid JM, Oerton JM, Dezateux C, Hindmarsh PC, Kelnar CJ, et al. Incidence and clinical features of congenital adrenal hyperplasia in Great Britain. Arch Dis Child. 2012; 97: 101-106. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22241917
3. 3. Kanaka GC, Chrousos GP, Dacou VC. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene. Clin Endocrinol (Oxf). 2015; 82: 543-549. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25041270
4. 4. Avilal NA, Premkumar A, Merke DP. TesticularAdrenal RestTissue in Congenital Adrenal Hyperplasia: Comparison of MR Imaging and Sonographic Findings. AJR. 1999; 172: 1003-1006. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10587136
5. 5. White PC, Speiser PW. Congenital Adrenal Hyperplasia due to21-Hydroxylase Deficiency. Endocrine Reviews. 2000; 21: 245-291. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28450075
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献